Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

Abstract Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nintedanib and pirfenidone. Historical outcom...

Descripció completa

Dades bibliogràfiques

Autors principals:	Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, Andrew H. Limper
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2021-07-01
Col·lecció:	BMC Pulmonary Medicine
Matèries:	Idiopathic pulmonary fibrosis Antifibrotics Hospitalization Critical care Mechanical ventilation
Accés en línia:	https://doi.org/10.1186/s12890-021-01607-2
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!